Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Intangibles (2025)

CG Oncology's Intangibles history spans 1 years, with the latest figure at $575000.0 for Q4 2025.

  • For Q4 2025, Intangibles changed N/A year-over-year to $575000.0; the TTM value through Dec 2025 reached $575000.0, changed N/A, while the annual FY2025 figure was $575000.0, N/A changed from the prior year.
  • Intangibles reached $575000.0 in Q4 2025 per CGON's latest filing, down from $1.7 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $1.7 million in Q3 2025 to a low of $575000.0 in Q4 2025.